Clinical Trial Update: An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. [Phase 2]

View source ↗

Summary

Status update on an open-label extension safety and efficacy study of QCZ484 in hypertensive patients. The trial is in Phase 2 and currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• QCZ484

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension (HTN) | Phase 2 | Status: NOT_YET_RECRUITING